| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.32 | 2e-18 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-11 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-10 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-10 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.31 | 1e-09 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-09 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |